Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001753926-24-000562
Filing Date
2024-03-19
Accepted
2024-03-19 13:40:26
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tlcc-20231231.htm   iXBRL 10-K 2200458
7 EXHIBIT 21.1 ex211_1.htm EX-21.1 18902
8 EXHIBIT 23.1 ex231_2.htm EX-23.1 6238
9 EXHIBIT 31.1 ex311_3.htm EX-31.1 19532
10 EXHIBIT 32.1 ex321_4.htm EX-32.1 15900
  Complete submission text file 0001753926-24-000562.txt   9853602

Data Files

Seq Description Document Type Size
2 DEFINITION tlcc-20231231_def.xml EX-101.DEF 362003
3 PRESENTATION tlcc-20231231_pre.xml EX-101.PRE 587123
4 CALCULATION tlcc-20231231_cal.xml EX-101.CAL 120139
5 LABEL tlcc-20231231_lab.xml EX-101.LAB 895801
6 SCHEMA tlcc-20231231.xsd EX-101.SCH 65207
77 EXTRACTED XBRL INSTANCE DOCUMENT tlcc-20231231_htm.xml XML 1464182
Mailing Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431
Business Address 4800 T-REX AVENUE SUITE 305 BOCA RATON FL 33431 561-443-5001
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55181 | Film No.: 24762184
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)